CASP9 and cancer: To gain an understanding of the reason that the anti-cancer capacity of TmSm34/48/84 was weaker than that of TmSm34/84, we used ZDOCK to simulate the docking for three multisite TmSm proteins with caspase-9 (Figure 5).